Skip to content

Opening book details…

About this Medicine article

Efficacy, Safety and Biomarker Data from SCarlet RoAD—a Global Phase 3 Study of Gantenerumab in Patients with Prodromal AD by Lasser, Robert; Scheltens, Philip; Dubois, Bruno; Nikolcheva, Tania; Retout, Sylvie; Volz, Dietmar; Csoboth, Csilla; Boada, Mercè is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Lasser, Robert; Scheltens, Philip; Dubois, Bruno; Nikolcheva, Tania; Retout, Sylvie; Volz, Dietmar; Csoboth, Csilla; Boada, Mercè
Publisher
American Psychiatric Publishing Inc; Elsevier ; Elsevier Inc.; Elsevier BV (ISSN 1064-7481)
Published
2016
Language
EN
Field
Medicine (Health Sciences)

More by Lasser, Robert; Scheltens, Philip; Dubois, Bruno; Nikolcheva, Tania; Retout, Sylvie; Volz, Dietmar; Csoboth, Csilla; Boada, Mercè

Browse all works by Lasser, Robert; Scheltens, Philip; Dubois, Bruno; Nikolcheva, Tania; Retout, Sylvie; Volz, Dietmar; Csoboth, Csilla; Boada, Mercè